"Electro Acupuncture in the Treatment and Management of Chemotherapy Induced Peripheral Neuropathy"

NCT02821442 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2018-01-26

No results posted yet for this study

Summary

To evaluate the effectiveness of Electro acupuncture (EA) for treatment of persistent painful CIPN symptoms in patients with stages 1-3 breast cancer treated with docetaxel chemotherapy 6 months prior

Conditions

Interventions

DEVICE

Acupuncture

Acupuncture points selected on the arms and legs using both acupuncture and electroacupuncture to assess effectiveness in alleviating neuropathic pain caused by chemotherapy in breast cancer patients

DEVICE

Sham Acupuncture

Placebo needles appear to penetrate but do not actually penetrate the skin

Sponsors & Collaborators

  • CancerCare Manitoba

    collaborator OTHER
  • University of Manitoba

    lead OTHER

Principal Investigators

  • Barbara Shay, PhD · University of Manitoba

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-02-29
Primary Completion
2018-07-31
Completion
2018-12-31

Countries

  • Canada

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02821442 on ClinicalTrials.gov